Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zea is an Australian-based health and wellness company that specializes in the development and commercialization of natural pain relief products derived from Kunzea ambigua oil. The company's flagship product line, Zea Relief, utilizes the therapeutic properties of Kunzea oil to target chronic pain, inflammatory conditions, and musculoskeletal disorders. Their portfolio includes TGA-listed topical formulations such as Kunzea Pain Relief Cream, which is marketed for the symptomatic relief of arthritis and joint swelling. Zea operates as a family-owned business, focusing on sustainable sourcing and evidence-based natural medicine for the consumer healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zea Relief.